NEW YORK (GenomeWeb) – IBM today announced a collaboration with Coriell Life Sciences and CareKinesis to analyze and store genetic data from elderly patients in an effort to improve and better manage their medication regimens.

Using SoftLayer, an IBM company, the partners are launching an initiative with Program for All Inclusive Care of the Elderly (PACE) "to enhance medication safety by better understanding how high-risk individuals respond to specific medications and drug treatments," they said in a statement. PACE cares for about 5,000 seniors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.